Back

Effects of SGLT2 inhibitors on the atrial rhythm: Sotagliflozin modifies the activity of NaV1.5

28 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Arrhythmias, atrial biology, and electrophysiology Ion Channels, Electrophysiology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Matthias Stelzle

University Hospital Heidelberg, Heidelberg (Germany)

7 More presentations in this session

Presentation thumbnail
Direct acute arrhythmic and negative inotropic effects of ibrutinib, but not doxorubicin, in human atrial myocardium
Mr Y. Berger (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Modulation of cytoplasmic polyadenylation element binding protein 3 changes electrophysiological features and calcium handling in cardiomyocytes
Mr C. Yang (Mannheim, DE)
Abstract Slides Video
Presentation thumbnail
Electrophysiological basis and pharmacological responses in short QT syndrome type 5: insights from iPSC-derived cardiomyocytes
Doctor Z. Xue (Mannheim, DE)
Abstract Slides Video
Presentation thumbnail
Sympathetic activation of L-type Ca2+ current and Na+/Ca2+ exchange current in canine ventricular cardiomyocytes
Doctor B. Horvath (Debrecen, HU)
Abstract Slides Video
Presentation thumbnail
Decreased diastolic calcium concentrations in patients with persistent versus paroxysmal atrial fibrillation
Doctor N. Ludwig (Muenster, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmias, atrial biology, and electrophysiology

The Event

Event poster

ESC Congress 2026

28 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Dapagliflozin exhibits class I antiarrhythmic effects which suppress action potential formation in human atrial cardiomyocytes
26 August 2022
thumbnail
Congress Presentation
Impact of health insurance on long-term mortality after percutaneous coronary intervention in acute coronary syndrome patients: a nationwide propensity-weighted analysis
30 August 2026
thumbnail
Congress Presentation
Association between SGLT2 inhibitor use and heart failure outcomes in anthracycline-exposed patients: a meta-analysis
30 August 2026
thumbnail
Congress Presentation
Low-frequency SCN5A variants and reduced functional scores associate with adverse arrhythmic outcomes
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources